, Tracking Stock Market Picks
Enter Symbol:
Ariad Pharmaceuticals, Inc. (ARIA) [hlAlert]

down 68.68 %

Ariad Pharmaceuticals, Inc. (ARIA) rated Buy by BofA/Merrill

Posted on: Monday,  Sep 10, 2012  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 09/10/2012, when the stock price was $22.29. Since
then, Ariad Pharmaceuticals, Inc. has lost 68.69% as of 01/19/2016's recent price of $6.98.
If you would have followed this BofA/Merrill's recommendation on ARIA, you would have lost 68.68% of your investment in 1226 days.

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2012 8:25 AM Buy
as of 12/31/2012
1 Week down  -5.84 %
1 Month down  -14.22 %
3 Months down  -20.77 %
1 YTD down  -13.95 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy